Founders Fund is about to close another $3B fund

Date:

Share post:


Founders Fund is on track to conclude fundraising of its third growth fund at the end of March, according to people close to the firm. The Peter Thiel-founded outfit is raising $3 billion, a source told TechCrunch and Axios also reported.

The fund, which is intended primarily for additional investments in its successful late-stage portfolio companies, is expected to be significantly oversubscribed.

Founders Fund’s previous $3.4 billion growth fund closed in early 2022 and is fully invested in companies like Rippling, which raised $200 million in April. Founders Fund is also leading Anduril’s newest raise, on track to be an up to $2.5 billion round at a valuation of $28 billion, CNBC reported. Sources confirmed to TechCrunch that its share will be the largest check Founders Fund has ever written. It’s unclear whether the firm’s reported $1 billion investment in Anduril would be out of that 2022 $3.4 billion fund.

The firm will not be raising a ninth core fund for early-stage companies because it was essentially already raised three years ago. Founders Fund reportedly slashed in half the size of its eighth venture capital fund of about $1.8 billion in 2023, Axios reported. The remaining $900 million was pushed into the firm’s core ninth fund. 

That’s one reason why there’s so much excitement for this new growth fund. While most multi-stage venture firms are raising larger funds, or at least trying to maintain their peak ZIRP-era sizes, Founders Fund is limiting its fund sizes.

Investors have reason to want in. Founders Fund has an enviable portfolio of growth companies which not only includes Anduril and SpaceX but Stripe, OpenAI, and Figma.

Founders Fund declined to comment.



Source link

Lisa Holden
Lisa Holden
Lisa Holden is a news writer for LinkDaddy News. She writes health, sport, tech, and more. Some of her favorite topics include the latest trends in fitness and wellness, the best ways to use technology to improve your life, and the latest developments in medical research.

Recent posts

Related articles

Tabby doubles valuation to $3.3B in $160M funding as it looks beyond BNPL and plans IPO

Consumer demand for credit options varies across regions, and for fintechs, understanding these differences is key to...

Shopify took down Kanye’s swastika T-shirt shop, but another antisemitic storefront still operates

Shopify took down Kanye West’s online store after the musician sold T-shirts with the swastika symbol. West, who...

Federal workers sue Elon Musk and DOGE to cut off data access

More than 100 current and former federal workers have sued Elon Musk and the Department of Government...

Apple Maps plans to show ‘Gulf of America,’ following Google

Apple Maps will soon rename the Gulf of Mexico to the Gulf of America, following similar changes...

ChatGPT may not be as power-hungry as once assumed

ChatGPT, OpenAI’s chatbot platform, may not be as power-hungry as once assumed. But its appetite largely depends...

Amazon tests sending customers directly to brands’ websites when it doesn’t stock their products

Remember that Christmas movie “Miracle on 34th Street,” where Macy’s in-store Santa, Kris Kringle, sends a frazzled...

Google’s I/O developer conference set for May 20-21

Google Tuesday confirmed that its annual developer conference is set for May 20-21, 2025. The event will...

Microsoft powers AI ambitions with 400 MW solar purchase

Microsoft has added another 389 megawatts of renewable power to its portfolio as the tech giant scrambles...